Oak Harbor Wealth Partners’s AbbVie ABBV Stock Holding History

Oak Harbor Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$993K	Sell	3,945 -149	-4%	-$32.1K	0.37%	69
2026 Q1	$890K	Buy	4,094 +37	+0.9%	+$8.21K	0.21%	102
2025 Q4	$927K	Sell	4,057 -26	-0.6%	-$5.92K	0.22%	102
2025 Q3	$945K	Hold	4,083	–	–	0.23%	95
2025 Q2	$758K	Hold	4,083	–	–	0.2%	103
2025 Q1	$855K	Buy	4,083 +13	+0.3%	+$2.53K	0.24%	88
2024 Q4	$723K	Hold	4,070	–	–	0.21%	99
2024 Q3	$804K	Buy	4,070 +157	+4%	+$29.3K	0.23%	98
2024 Q2	$671K	Sell	3,913 -175	-4%	-$29K	0.21%	98
2024 Q1	$744K	Sell	4,088 -100	-2%	-$17.2K	0.23%	92
2023 Q4	$649K	Sell	4,188 -100	-2%	-$14.6K	0.22%	99
2023 Q3	$639K	Sell	4,288 -131	-3%	-$19.2K	0.23%	97
2023 Q2	$595K	Buy	4,419 +100	+2%	+$14.7K	0.2%	102
2023 Q1	$688K	Sell	4,319 -58	-1%	-$8.87K	0.25%	84
2022 Q4	$707K	Hold	4,377	–	–	0.27%	79
2022 Q3	$587K	Hold	4,377	–	–	0.23%	88
2022 Q2	$670K	Sell	4,377 -230	-5%	-$35.1K	0.27%	82
2022 Q1	$747K	Buy	4,607 +30	+0.7%	+$4.36K	0.25%	83
2021 Q4	$620K	Buy	+4,577	New	+$541K	0.21%	89

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oak Harbor Wealth Partners's ABBV Position: Q2 2026 in Review

Oak Harbor Wealth Partners reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $32.1K and leaving 3,945 shares worth $993K. The position accounts for 0.37% of the portfolio, ranked #69.

Oak Harbor Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Oak Harbor Wealth Partners held 3,945 shares of AbbVie worth $993K as of Q2 2026.
Oak Harbor Wealth Partners sold 149 AbbVie shares in Q2 2026, an estimated $32.1K.
AbbVie made up 0.37% of Oak Harbor Wealth Partners's portfolio in Q2 2026, its #69 holding.
Oak Harbor Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.